Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 1809262)

Published in Clin Exp Immunol on January 01, 2005

Authors

A Hasebe1, S M F Akbar, S Furukawa, N Horiike, M Onji

Author Affiliations

1: Third Department of Internal Medicine, Ehime University School of Medicine, Japan.

Articles cited by this

The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09

Hepatitis B virus immunopathogenesis. Annu Rev Immunol (1995) 8.62

Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science (1996) 5.31

Dendritic cell immunotherapy: mapping the way. Nat Med (2004) 4.28

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med (1995) 3.34

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology (2001) 2.49

Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci U S A (1989) 2.10

Some interfaces of dendritic cell biology. APMIS (2003) 1.79

Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol (2003) 1.53

Hepatitis B infection: pathogenesis and management. J Hepatol (2000) 1.42

Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol (1996) 1.36

Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood (2003) 1.33

Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol (1999) 1.27

Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol (2002) 1.17

Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology (1993) 1.13

Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine (2003) 1.10

Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol (2004) 1.08

Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection. Int J Exp Pathol (1998) 1.07

Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immunol (1997) 1.05

Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol (2004) 1.04

Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier. Immunology (1999) 0.97

Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer. Int J Mol Med (2004) 0.95

Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med (2003) 0.91

Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin Exp Immunol (2003) 0.90

A novel and effective approach of developing aggressive experimental autoimmune gastritis in neonatal thymectomized BALB/c mouse by polyinosinic:polycytidylic acid. Clin Exp Immunol (2004) 0.88

Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83-positive mature dendritic cells at the vicinity of focal and confluent necrosis. Hepatol Res (2001) 0.84

Vaccine therapy for hepatitis B virus carrier. Curr Drug Targets Infect Disord (2004) 0.81

Articles by these authors

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62

Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol (1990) 1.94

Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am Heart J (1973) 1.83

Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem (1991) 1.73

Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci U S A (2003) 1.69

Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol (2001) 1.67

Neurotoxicity of human eosinophils towards peripheral nerves. J Neurol Sci (1989) 1.52

Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis. Lupus (2005) 1.51

Interferon therapy for patients more than 60 years of age with chronic hepatitis C. J Gastroenterol Hepatol (1995) 1.48

Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation (1996) 1.45

Radio-ulnar synostosis, short stature, microcephaly, scoliosis, and mental retardation. Am J Med Genet (1995) 1.40

Myocardial oxygen utilization after reversible global ischemia. J Thorac Cardiovasc Surg (1990) 1.40

Development of bronchial asthma after wheezing associated with respiratory infection in infancy. Acta Paediatr (1995) 1.40

Superantigens and Kawasaki disease. Immunol Today (1991) 1.39

Amiodarone for atrial fibrillation during off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2001) 1.39

Alanylglutamine-enriched total parenteral nutrition improves protein metabolism more than branched chain amino acid-enriched total parenteral nutrition in protracted peritonitis. J Trauma (1997) 1.39

Off-pump extraction of an embedded high posterior left ventricular bullet utilizing a new cardiac stabilization device. J Trauma (2001) 1.39

Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol (1999) 1.35

Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes. Biochem Biophys Res Commun (1998) 1.31

Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.29

Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest (2001) 1.28

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis/encephalopathy. Neurology (1998) 1.27

Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol (1999) 1.27

Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother (2001) 1.26

Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol (2011) 1.26

Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology (1996) 1.21

Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol (2005) 1.21

Washout measurement of radioisotope implanted by radioactive beams in the rabbit. Phys Med Biol (2003) 1.17

Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol (1999) 1.16

Perineural spread of adenoid cystic carcinoma in the oral and maxillofacial regions: evaluation with contrast-enhanced CT and MRI. Dentomaxillofac Radiol (2012) 1.16

Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg (1996) 1.16

Relationship between resting hypercapnia and physiologic parameters before and after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.16

Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its' intracellular expression in human megakaryocytes. Blood (1999) 1.15

Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus. Eur J Clin Invest (2001) 1.15

Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood (1997) 1.15

Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys (2001) 1.13

Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology (1993) 1.13

Effect of aeration and unsaturated fatty acids on expression of the Saccharomyces cerevisiae alcohol acetyltransferase gene. Appl Environ Microbiol (1997) 1.12

Molecular cloning and characterization of a novel gene, CORS26, encoding a putative secretory protein and its possible involvement in skeletal development. J Biol Chem (2000) 1.11

Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg (1997) 1.08

Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection. Int J Exp Pathol (1998) 1.07

Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen. Immunology (1996) 1.07

Thiazolidine derivatives as potent inhibitors specific for prolyl endopeptidase. J Biochem (1988) 1.06

Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol (2004) 1.06

Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin Exp Immunol (2002) 1.05

Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res (2000) 1.05

Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis (2007) 1.05

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol (1999) 1.03

Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol (1999) 1.03

Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status. J Clin Pathol (1998) 1.02

Effect of circulatory assist devices on stunned myocardium. Ann Thorac Surg (1990) 1.02

Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells. Immunology (1997) 1.01

Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis. Cancer Lett (2001) 1.01

Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum Mutat (2000) 0.99

Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol (2002) 0.99

Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett (2000) 0.98

Route of nutritional supply influences local, systemic, and remote organ responses to intraperitoneal bacterial challenge. Ann Surg (1996) 0.98

Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol (1999) 0.98

The role of gender in heart transplantation. Ann Thorac Surg (1998) 0.98

Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clin Biochem (2001) 0.98

NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol (2001) 0.98

Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur J Gastroenterol Hepatol (2001) 0.97

Malignant mixed Müllerian tumor of the fallopian tube: a case report. Eur J Gynaecol Oncol (2012) 0.97

Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier. Immunology (1999) 0.97

Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci Biotechnol Biochem (2000) 0.96

Dietary restriction impairs neutrophil exudation by reducing CD11b/CD18 expression and chemokine production. Arch Surg (2001) 0.96

Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases. Hepatogastroenterology (1988) 0.96

Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease. Clin Exp Immunol (1999) 0.96

Changes in hemodynamics and bradykinin concentration in coronary sinus blood in experimental coronary artery occlusion. Jpn Heart J (1977) 0.96

Hepatitis C virus clearance is prominent in women in an endemic area. J Gastroenterol Hepatol (2000) 0.96

Production of gamma-aminobutyric acid by cheese starters during cheese ripening. J Dairy Sci (1998) 0.96

Histopathologic and radiographic findings of the simple bone cyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 0.95

Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys (1996) 0.95

Amyloidosis localized in the sigmoid colon. J Gastroenterol (1996) 0.95

Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology (2001) 0.95

Evaluation of core decompression for early osteonecrosis of the femoral head. Arch Orthop Trauma Surg (2000) 0.95

Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis. Cancer Lett (2000) 0.95

Present status of autoimmune hepatitis in Japan. Gastroenterol Jpn (1993) 0.95

CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol (2000) 0.94

The dsbA-dsbB disulfide bond formation system of Burkholderia cepacia is involved in the production of protease and alkaline phosphatase, motility, metal resistance, and multi-drug resistance. Microbiol Immunol (2000) 0.94

Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture. Biochem Biophys Res Commun (1986) 0.94

Increase of cord blood cytokine-producing T cells in intrauterine infection. Pediatr Int (2001) 0.93

Comparison of outer membrane protein genes omp and pmp in the whole genome sequences of Chlamydia pneumoniae isolates from Japan and the United States. J Infect Dis (2000) 0.93